Greenberg Bruce's Form 4 filing
Aldeyra Therapeutics, Inc. (ALDX) · filed Aug 14, 2024
- Accession no.
- 0000950170-24-097070
- Filed
- Aug 14, 2024
- Trade date
- Aug 12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $51.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Greenberg BruceCIK 0001928391 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | Common Stock | SSaleDisposed | −10,834 | $4.74 | −$51,353.16 | 126,382 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.